tiprankstipranks
Trending News
More News >
NOF Corporation (JP:4403)
:4403
Advertisement

NOF (4403) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4403

NOF

(OTC:4403)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 4o)
Rating:69Neutral
Price Target:
¥2,898.00
▲(10.38% Upside)
NOF's overall stock score is driven by strong financial performance, which is the most significant factor. The company's stable profitability and low financial risk enhance its appeal. However, technical analysis indicates potential short-term weakness, and the valuation is moderate, balancing the overall score.

NOF (4403) vs. iShares MSCI Japan ETF (EWJ)

NOF Business Overview & Revenue Model

Company DescriptionNOF Corporation manufactures chemicals Japan, rest of Asia, and internationally. The company operates through Functional Chemicals, Life Science, and Explosive & Propulsion segments. The Functional Chemicals segment offers fatty acids and glycerin, fatty acid derivatives, and surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, functional polymers, functional films, and electronic materials, as well as materials for anti-corrosion. The Life Science segment provides MPC-related products, raw materials for DDS drug formulation, edible oils, and functional foods. The Explosive & Propulsion segment offers industrial explosives, defense-related explosives, rocket propellant, automotive safety devices, and metal manufactured products. The company is also involved in logistics, insurance agency, and real estate businesses. NOF Corporation was founded in 1937 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyNOF Corporation generates revenue through the sale of its chemical products to a variety of industries. Its key revenue streams include the marketing and distribution of functional chemicals like surfactants and polymerizable monomers, which are essential in the manufacturing processes of personal care products and industrial applications. Additionally, the company earns from its life science division by providing pharmaceutical intermediates and raw materials for drug production. The electronic materials sector contributes to revenue by supplying advanced materials used in the production of semiconductors and other electronic components. Strategic partnerships and collaborations with industry leaders further enhance its market reach and revenue potential.

NOF Financial Statement Overview

Summary
NOF exhibits strong financial health with consistent revenue growth, robust profitability, and a solid balance sheet. The company maintains a low debt-to-equity ratio and high equity ratio, reducing financial risk. Despite a slight decline in operating cash flow, overall financial management is effective.
Income Statement
85
Very Positive
NOF has demonstrated consistent revenue growth over the past years, with a significant increase from 222.25 billion in 2024 to 238.31 billion in 2025, a growth rate of 7.22%. Gross profit margins have remained strong, and net profit margins have improved, reflecting effective cost management and operational efficiency. The EBIT and EBITDA margins are healthy, indicating robust profitability. Overall, NOF's income statement reflects a strong financial performance, marked by growth and profitability.
Balance Sheet
90
Very Positive
NOF's balance sheet is characterized by a strong equity position with a high equity ratio, indicating financial stability. The debt-to-equity ratio is low, suggesting conservative leverage and low financial risk. The return on equity is impressive, showcasing efficient use of shareholders' funds to generate profits. Overall, the balance sheet presents a solid financial position with minimal risk exposure.
Cash Flow
78
Positive
The operating cash flow remains strong, although it has seen a slight decline from the previous year. The free cash flow has shown positive growth, indicating effective capital management. The ratios of operating cash flow and free cash flow to net income are healthy, reflecting solid cash generation capabilities. However, the decline in operating cash flow warrants attention for future cash flow stability.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue239.26B238.31B222.25B217.71B192.64B172.65B
Gross Profit84.44B85.15B79.49B75.94B68.93B57.39B
EBITDA53.66B58.88B49.08B46.98B43.95B39.72B
Net Income34.06B36.50B33.99B33.97B26.69B23.30B
Balance Sheet
Total Assets371.76B357.20B341.45B309.44B289.63B271.54B
Cash, Cash Equivalents and Short-Term Investments100.18B87.06B91.74B92.52B85.43B78.67B
Total Debt4.36B5.04B5.17B4.84B5.63B9.94B
Total Liabilities91.98B77.64B75.54B69.44B67.93B68.02B
Stockholders Equity278.79B278.53B265.00B239.18B220.93B202.79B
Cash Flow
Free Cash Flow0.0012.64B12.22B17.11B19.98B24.74B
Operating Cash Flow0.0028.98B29.97B23.33B27.39B30.73B
Investing Cash Flow0.00-13.75B-14.96B-709.00M-8.76B1.89B
Financing Cash Flow0.00-22.02B-17.10B-16.17B-15.31B-8.04B

NOF Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2625.50
Price Trends
50DMA
2733.86
Negative
100DMA
2715.84
Negative
200DMA
2392.39
Positive
Market Momentum
MACD
-32.52
Negative
RSI
46.26
Neutral
STOCH
54.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4403, the sentiment is Neutral. The current price of 2625.5 is below the 20-day moving average (MA) of 2634.20, below the 50-day MA of 2733.86, and above the 200-day MA of 2392.39, indicating a neutral trend. The MACD of -32.52 indicates Negative momentum. The RSI at 46.26 is Neutral, neither overbought nor oversold. The STOCH value of 54.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4403.

NOF Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$579.66B11.6310.06%2.70%4.35%7.88%
71
Outperform
$540.08B13.046.42%3.59%-6.27%40.98%
69
Neutral
$620.10B18.1712.59%1.77%4.89%-3.79%
67
Neutral
$710.15B46.971.78%4.04%-0.91%-74.07%
64
Neutral
$1.05T30.492.45%4.25%-0.06%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
45
Neutral
$222.75B11.14-1.26%4.79%-0.53%-117.46%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4403
NOF
2,625.50
47.76
1.85%
JP:5201
AGC
4,939.00
455.04
10.15%
JP:4088
Air Water
2,576.50
643.35
33.28%
JP:4182
Mitsubishi Gas Chemical Company
2,818.00
149.37
5.60%
JP:4183
Mitsui Chemicals
3,737.00
220.61
6.27%
JP:4208
UBE Industries
2,296.50
-187.08
-7.53%

NOF Corporate Events

NOF Corporation Reports Q1 2025 Financial Results with Mixed Performance
Aug 6, 2025

NOF Corporation reported its consolidated financial results for the three months ending June 30, 2025, showing a slight increase in net sales by 1.7% compared to the previous year. However, the company experienced a decline in operating profit, ordinary profit, and profit attributable to owners of the parent, indicating challenges in maintaining profitability. The company maintains a strong equity-to-asset ratio, and its earnings forecast for the fiscal year ending March 31, 2026, anticipates modest growth in net sales and profits, suggesting a cautious outlook for the future.

NOF Corporation Completes Treasury Share Purchase
Aug 6, 2025

NOF Corporation has completed the purchase of 136,000 treasury shares for a total of 408,877,150 yen, as part of a resolution made by its Board of Directors. This move is part of a broader strategy to purchase up to 5,000,000 shares, indicating a significant investment in its own stock, which could impact shareholder value and market perception.

NOF Corporation Advances Treasury Share Buyback Strategy
Jul 1, 2025

NOF Corporation announced the purchase of 1,029,600 treasury shares for approximately 2.75 billion yen, conducted through open-market transactions on the Tokyo Stock Exchange. This move is part of a broader strategy approved by the Board of Directors to acquire up to 5 million shares by September 2025, reflecting the company’s efforts to enhance shareholder value and optimize capital structure.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 01, 2025